[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@jmatlus Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1532317872407576576.png) @jmatlus JM

JM posts on X about $mrna, $nvda, $lly, $msft the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::1532317872407576576/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1532317872407576576/c:line/m:interactions.svg)

- X Week XXXXX +780%
- X Month XXXXX +99%
- X Months XXXXX -XX%
- X Year XXXXXX -XX%

### Mentions: XX [#](/creator/twitter::1532317872407576576/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1532317872407576576/c:line/m:posts_active.svg)

- X Week XX +433%
- X Month XX +286%
- X Months XX -XX%
- X Year XXX +2.50%

### Followers: XXX [#](/creator/twitter::1532317872407576576/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1532317872407576576/c:line/m:followers.svg)

- X Week XXX +3.10%
- X Month XXX -X%
- X Months XXX +33%
- X Year XXX -XX%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1532317872407576576/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1532317872407576576/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1532317872407576576/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [technology brands](/list/technology-brands)  XXXXX% [currencies](/list/currencies)  XXXXX% [automotive brands](/list/automotive-brands)  XXXXX% [finance](/list/finance)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$mrna](/topic/$mrna) #6, [$nvda](/topic/$nvda) #876, [$lly](/topic/$lly) #20, [$msft](/topic/$msft) #70, [$amgn](/topic/$amgn) #12, [$pfe](/topic/$pfe) #62, [$bmy](/topic/$bmy) #14, [$meta](/topic/$meta) #160, [meta](/topic/meta) 23.08%, [$abbv](/topic/$abbv) #29

**Top assets mentioned**
[Moderna Inc (MRNA)](/topic/$mrna) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Eli Lilly and Company (LLY)](/topic/$lly) [Microsoft Corp. (MSFT)](/topic/$msft) [Amgen, Inc. (AMGN)](/topic/$amgn) [Pfizer, Inc. (PFE)](/topic/$pfe) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Metadium (META)](/topic/$meta) [AbbVie Inc (ABBV)](/topic/$abbv) [Apple, Inc. (AAPL)](/topic/$aapl) [Alphabet Inc Class A (GOOGL)](/topic/$googl) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [AstraZeneca PLC (AZN)](/topic/$azn) [Tesla, Inc. (TSLA)](/topic/$tsla) [Amazon.com, Inc. (AMZN)](/topic/$amzn) [Advanced Micro Devices (AMD)](/topic/$amd) [Johnson & Johnson (JNJ)](/topic/$jnj) [Super Micro Computer, Inc. Common Stock (SMCI)](/topic/$smci) [Intel Corporation (INTC)](/topic/$intc) [Netflix Inc (NFLX)](/topic/$nflx) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Vertex Protocol (VRTX)](/topic/$vrtx)
### Top Social Posts [#](/creator/twitter::1532317872407576576/posts)
---
Top posts by engagements in the last XX hours

"Moderna ($MRNA) dropped a solid pipeline update today focusing beyond Covid cancer rare diseases new vax tech etc. No hype yet no big upgrades. Thats how smart money plays it. Once it runs XX% youll suddenly see analyst confidence and headlines everywhere. $MRNA $PFE $LLY $AMGN $NVDA $TSLA $AAPL $MSFT $GOOGL"  
[X Link](https://x.com/jmatlus/status/1980318881983189125) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:03Z XXX followers, XXX engagements


"$MRNA pipeline quietly expanding into oncology flu and rare disease programs. No noise yet but the direction looks strong. Institutions usually move before the headlines. $MRNA $LLY $BMY $AMGN $NVDA $MSFT $GOOGL"  
[X Link](https://x.com/jmatlus/status/1980320675299831963) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:10Z XXX followers, XX engagements


"Biotech + AI convergence is getting real. $MRNAs next-gen trials $LLYs data platform $NVDAs bio-foundry stack all pointing the same way. The next breakout wont be hype itll be data-backed. $MRNA $LLY $NVDA $AMZN $GOOG $MSFT $META"  
[X Link](https://x.com/jmatlus/status/1980320761769500707) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:10Z XXX followers, XXX engagements


"$MRNA quietly expanding beyond Covid. Cancer flu and rare disease programs now in motion. No hype. No upgrades. Just silence from the big houses. Once its up XX% theyll call it a turnaround story. Smart eyes accumulate when the street sleeps. $MRNA $PFE $LLY $AMGN $JNJ $NVDA $AAPL $MSFT $GOOGL"  
[X Link](https://x.com/jmatlus/status/1980319053156589762) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:03Z XXX followers, XXX engagements


"The line between biotech and tech is fading fast. $MRNAs new mRNA platform is as much about data and AI as biology. Todays quiet move might be tomorrows next $NVDA-style run. $MRNA $NVDA $AMD $SMCI $MSFT $GOOG $META $LLY $REGN $ABBV"  
[X Link](https://x.com/jmatlus/status/1980319790943334528) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:06Z XXX followers, XX engagements


"No analyst upgrades no noise $MRNA moving slow and silent. Big funds often build before they talk. Watch volumes not just the news. $MRNA $PFE $AZN $AMGN $ABBV $NVDA $AAPL $MSFT"  
[X Link](https://x.com/jmatlus/status/1980320837434765420) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:10Z XXX followers, XXX engagements


"$MRNA is waking up. Moderna just dropped data that could redefine the flu-vaccine market. 🧬 mRNA-1010 (seasonal flu) = XXXX% higher efficacy than current standard-dose vaccines. 🦠 mRNA-1018 (H5 pandemic flu) = XXXX% protective response after just two doses. This isnt another COVID replay its Modernas second act. From pandemic hero to multi-vaccine powerhouse scaling faster than $PFE $BNTX or $NVAX ever did. 💥 Seasonal flu dominance. 💥 Pandemic preparedness edge. 💥 mRNA platform advantage rapid strain updates lower dev time global scalability. The biotech rotation is coming. Smart money"  
[X Link](https://x.com/jmatlus/status/1979886718430916616) [@jmatlus](/creator/x/jmatlus) 2025-10-19T12:25Z XXX followers, 1221 engagements


"$EICHERMOT.NS Valuation stretched GST turns headwind 🚨 Indias new GST slabs flip the script for Royal Enfield. XXX cc: GST cut to XX % XX % cheaper XXX cc: GST hiked to XX % XX % costlier August 2025 data: XXX cc XXXX k units (+61 % YoY) XXX cc XXXX k units (+23 % YoY) High-margin XXX / XXX cc models may see XX % volume hit erasing gains from cheaper XXX cc bikes. Premium XXX cc = XX % volume but XX % profit. GST XXX margin compression slower EPS growth ( XX %). Stock trades at XX P/E already pricing 2025 % CAGR. If it de-rates to XX 2025 % downside possible. Until exports or a new platform"  
[X Link](https://x.com/jmatlus/status/1979905900669174084) [@jmatlus](/creator/x/jmatlus) 2025-10-19T13:42Z XXX followers, XX engagements


"Avg Royal Enfield XXX sells X L ex-showroom. At XX % margin XX k profit per bike. With stock at XX P/E market values each XX k profit at XX L X the selling price Thats a consumer-brand multiple on a cyclical auto business. Even a small margin slip or XX % GST-led slowdown in XXX cc sales can break this equation fast. #EicherMotors $EICHERMOT #RoyalEnfield #AutoStocks #GST #IndiaMarkets $TATAMOTORS $MARUTI $BAJAJ-AUTO $TVSMOTOR $HEROMOTOCO $M&M"  
[X Link](https://x.com/jmatlus/status/1979906328102322600) [@jmatlus](/creator/x/jmatlus) 2025-10-19T13:43Z XXX followers, XX engagements


"Everyone ignoring $MRNA now but the company just dropped key pipeline moves beyond Covid cancer RSV rare diseases. No hype yet. Big funds usually wake up after the first XX% move. Classic quiet-phase accumulation. Watch the crossover of biotech + AI + data in the next leg. $MRNA $BMY $REGN $AZN $ABBV $META $AMD $INTC $GOOG"  
[X Link](https://x.com/jmatlus/status/1980319215828758649) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:04Z XXX followers, XX engagements


"$MRNA quietly pushing a deeper pipeline beyond Covid cancer flu RSV rare diseases and new mRNA platforms. No noise. No upgrades. Just silent accumulation. Once its up XX% youll see analyst confidence and media hype everywhere. Early phase for those who read between the lines. $MRNA $PFE $LLY $BMY $AMGN $REGN $AZN $ABBV $GILD $VRTX $NVDA $TSLA $AAPL $MSFT $GOOGL $META $AMZN $NFLX $INTC $AVGO $SMCI"  
[X Link](https://x.com/jmatlus/status/1980319436931252243) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:05Z XXX followers, XX engagements


"Everyone hunts hype. Real investors hunt silence. $MRNA just expanded beyond Covid into cancer and rare diseases. No spotlight yet but the blueprint for a rebound is right there. $MRNA $BMY $AMGN $LLY $ABBV $NVDA $AAPL $MSFT $META $GOOG"  
[X Link](https://x.com/jmatlus/status/1980319732462239781) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:06Z XXX followers, XXX engagements


"Todays focus turning to pharma innovation again. $MRNA pipeline shift + $LLYs obesity run + $BMY cancer trials healthcare is quietly resetting leadership. $MRNA $LLY $BMY $AMGN $ABBV $REGN $TSLA $NVDA $GOOGL"  
[X Link](https://x.com/jmatlus/status/1980327177985065242) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:36Z XXX followers, XX engagements


"Every big story begins in silence. $MRNA is writing one now moving beyond Covid building long-term assets. Patience pays noise comes later. $MRNA $PFE $BNTX $LLY $BMY $AZN $AMZN $MSFT $META $NVDA"  
[X Link](https://x.com/jmatlus/status/1980327779246948425) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:38Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@jmatlus JM

JM posts on X about $mrna, $nvda, $lly, $msft the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

X Week XXXXX +780%
X Month XXXXX +99%
X Months XXXXX -XX%
X Year XXXXXX -XX%

Mentions: XX #

X Week XX +433%
X Month XX +286%
X Months XX -XX%
X Year XXX +2.50%

Followers: XXX #

X Week XXX +3.10%
X Month XXX -X%
X Months XXX +33%
X Year XXX -XX%

CreatorRank: XXXXXXXXX #

Social Influence #

Social category influence stocks XXXXX% technology brands XXXXX% currencies XXXXX% automotive brands XXXXX% finance XXXX% cryptocurrencies XXXX%

Social topic influence $mrna #6, $nvda #876, $lly #20, $msft #70, $amgn #12, $pfe #62, $bmy #14, $meta #160, meta 23.08%, $abbv #29

Top assets mentioned Moderna Inc (MRNA) NVIDIA Corp. (NVDA) Eli Lilly and Company (LLY) Microsoft Corp. (MSFT) Amgen, Inc. (AMGN) Pfizer, Inc. (PFE) Bristol-Myers Squibb Co (BMY) Metadium (META) AbbVie Inc (ABBV) Apple, Inc. (AAPL) Alphabet Inc Class A (GOOGL) Regeneron Pharmaceuticals Inc (REGN) AstraZeneca PLC (AZN) Tesla, Inc. (TSLA) Amazon.com, Inc. (AMZN) Advanced Micro Devices (AMD) Johnson & Johnson (JNJ) Super Micro Computer, Inc. Common Stock (SMCI) Intel Corporation (INTC) Netflix Inc (NFLX) Gilead Sciences, Inc. (GILD) Vertex Protocol (VRTX)

Top Social Posts #

Top posts by engagements in the last XX hours

"Moderna ($MRNA) dropped a solid pipeline update today focusing beyond Covid cancer rare diseases new vax tech etc. No hype yet no big upgrades. Thats how smart money plays it. Once it runs XX% youll suddenly see analyst confidence and headlines everywhere. $MRNA $PFE $LLY $AMGN $NVDA $TSLA $AAPL $MSFT $GOOGL"
X Link @jmatlus 2025-10-20T17:03Z XXX followers, XXX engagements

"$MRNA pipeline quietly expanding into oncology flu and rare disease programs. No noise yet but the direction looks strong. Institutions usually move before the headlines. $MRNA $LLY $BMY $AMGN $NVDA $MSFT $GOOGL"
X Link @jmatlus 2025-10-20T17:10Z XXX followers, XX engagements

"Biotech + AI convergence is getting real. $MRNAs next-gen trials $LLYs data platform $NVDAs bio-foundry stack all pointing the same way. The next breakout wont be hype itll be data-backed. $MRNA $LLY $NVDA $AMZN $GOOG $MSFT $META"
X Link @jmatlus 2025-10-20T17:10Z XXX followers, XXX engagements

"$MRNA quietly expanding beyond Covid. Cancer flu and rare disease programs now in motion. No hype. No upgrades. Just silence from the big houses. Once its up XX% theyll call it a turnaround story. Smart eyes accumulate when the street sleeps. $MRNA $PFE $LLY $AMGN $JNJ $NVDA $AAPL $MSFT $GOOGL"
X Link @jmatlus 2025-10-20T17:03Z XXX followers, XXX engagements

"The line between biotech and tech is fading fast. $MRNAs new mRNA platform is as much about data and AI as biology. Todays quiet move might be tomorrows next $NVDA-style run. $MRNA $NVDA $AMD $SMCI $MSFT $GOOG $META $LLY $REGN $ABBV"
X Link @jmatlus 2025-10-20T17:06Z XXX followers, XX engagements

"No analyst upgrades no noise $MRNA moving slow and silent. Big funds often build before they talk. Watch volumes not just the news. $MRNA $PFE $AZN $AMGN $ABBV $NVDA $AAPL $MSFT"
X Link @jmatlus 2025-10-20T17:10Z XXX followers, XXX engagements

"$MRNA is waking up. Moderna just dropped data that could redefine the flu-vaccine market. 🧬 mRNA-1010 (seasonal flu) = XXXX% higher efficacy than current standard-dose vaccines. 🦠 mRNA-1018 (H5 pandemic flu) = XXXX% protective response after just two doses. This isnt another COVID replay its Modernas second act. From pandemic hero to multi-vaccine powerhouse scaling faster than $PFE $BNTX or $NVAX ever did. 💥 Seasonal flu dominance. 💥 Pandemic preparedness edge. 💥 mRNA platform advantage rapid strain updates lower dev time global scalability. The biotech rotation is coming. Smart money"
X Link @jmatlus 2025-10-19T12:25Z XXX followers, 1221 engagements

"$EICHERMOT.NS Valuation stretched GST turns headwind 🚨 Indias new GST slabs flip the script for Royal Enfield. XXX cc: GST cut to XX % XX % cheaper XXX cc: GST hiked to XX % XX % costlier August 2025 data: XXX cc XXXX k units (+61 % YoY) XXX cc XXXX k units (+23 % YoY) High-margin XXX / XXX cc models may see XX % volume hit erasing gains from cheaper XXX cc bikes. Premium XXX cc = XX % volume but XX % profit. GST XXX margin compression slower EPS growth ( XX %). Stock trades at XX P/E already pricing 2025 % CAGR. If it de-rates to XX 2025 % downside possible. Until exports or a new platform"
X Link @jmatlus 2025-10-19T13:42Z XXX followers, XX engagements

"Avg Royal Enfield XXX sells X L ex-showroom. At XX % margin XX k profit per bike. With stock at XX P/E market values each XX k profit at XX L X the selling price Thats a consumer-brand multiple on a cyclical auto business. Even a small margin slip or XX % GST-led slowdown in XXX cc sales can break this equation fast. #EicherMotors $EICHERMOT #RoyalEnfield #AutoStocks #GST #IndiaMarkets $TATAMOTORS $MARUTI $BAJAJ-AUTO $TVSMOTOR $HEROMOTOCO $M&M"
X Link @jmatlus 2025-10-19T13:43Z XXX followers, XX engagements

"Everyone ignoring $MRNA now but the company just dropped key pipeline moves beyond Covid cancer RSV rare diseases. No hype yet. Big funds usually wake up after the first XX% move. Classic quiet-phase accumulation. Watch the crossover of biotech + AI + data in the next leg. $MRNA $BMY $REGN $AZN $ABBV $META $AMD $INTC $GOOG"
X Link @jmatlus 2025-10-20T17:04Z XXX followers, XX engagements

"$MRNA quietly pushing a deeper pipeline beyond Covid cancer flu RSV rare diseases and new mRNA platforms. No noise. No upgrades. Just silent accumulation. Once its up XX% youll see analyst confidence and media hype everywhere. Early phase for those who read between the lines. $MRNA $PFE $LLY $BMY $AMGN $REGN $AZN $ABBV $GILD $VRTX $NVDA $TSLA $AAPL $MSFT $GOOGL $META $AMZN $NFLX $INTC $AVGO $SMCI"
X Link @jmatlus 2025-10-20T17:05Z XXX followers, XX engagements

"Everyone hunts hype. Real investors hunt silence. $MRNA just expanded beyond Covid into cancer and rare diseases. No spotlight yet but the blueprint for a rebound is right there. $MRNA $BMY $AMGN $LLY $ABBV $NVDA $AAPL $MSFT $META $GOOG"
X Link @jmatlus 2025-10-20T17:06Z XXX followers, XXX engagements

"Todays focus turning to pharma innovation again. $MRNA pipeline shift + $LLYs obesity run + $BMY cancer trials healthcare is quietly resetting leadership. $MRNA $LLY $BMY $AMGN $ABBV $REGN $TSLA $NVDA $GOOGL"
X Link @jmatlus 2025-10-20T17:36Z XXX followers, XX engagements

"Every big story begins in silence. $MRNA is writing one now moving beyond Covid building long-term assets. Patience pays noise comes later. $MRNA $PFE $BNTX $LLY $BMY $AZN $AMZN $MSFT $META $NVDA"
X Link @jmatlus 2025-10-20T17:38Z XXX followers, XXX engagements